T1	Intervention 65 122	postmenopausal patients with metastatic breast carcinoma:
T2	Intervention 212 275	Breast cancer patients with prior response to endocrine therapy
T3	Intervention 446 470	post menopausal patients
T4	Intervention 598 669	In 2 multiinstitutional prospective trials, 683 postmenopausal patients
